MM&M Awards: Who's Going to Shine in 2009

Despite an increasingly difficult environmental for healthcare marketers, the MM&M Awards program continues to grow in size, stature and relevance—as evidenced by last year's record-breaking 830 submissions. So why such a clamor to win gold? It's because this program is judged fairly, independently and with the authority of a large panel of industry experts. We go to extraordinary lengths to make sure that the best work wins. Just ask a seasoned judge:

“Many areas of marketing communications are highly subjective, more art than science,” says Joe Shields, product director for Enbrel at Wyeth. “However, the judges for the MM&M Awards do their level best to assess fairly entries based on objective criteria and business impact, when provided. I continue to serve as a judge (three times so far) because it is a valuable part of my continuing marketing education. I can count on a few entries each year that make me say, ‘Wow, I wish I had done that!'”
You must be a registered member of MMM to post a comment.

Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.